Related Experiment Video
Updated: Nov 19, 2025

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research
Published on: November 3, 2023
In-hospital cardiac arrest in patients with coronavirus 2019
Oscar J L Mitchell1, Eugene Yuriditsky2, Nicholas J Johnson3
1Pulmonary, Allergy, and Critical Care Division, University of Pennsylvania, United States; Center for Resuscitation Science, University of Pennsylvania, United States.
Insights
Survival after in-hospital cardiac arrest (IHCA) for COVID-19 patients was low at 12.3%. Outcomes varied significantly between hospitals, suggesting a need for standardized care protocols for these critically ill patients.
Area of Science:
- Critical Care Medicine
- Cardiology
- Infectious Diseases
Background:
- Coronavirus Disease 2019 (COVID-19) has caused significant global mortality.
- Clinical outcomes for hospitalized COVID-19 patients experiencing in-hospital cardiac arrest (IHCA) remain poorly understood.
- Understanding IHCA in COVID-19 is crucial for improving patient care and survival rates.
Purpose of the Study:
- To characterize clinical outcomes of IHCA in patients with active COVID-19.
- To identify patient- and hospital-level factors associated with 30-day survival after IHCA in COVID-19 patients.
Main Methods:
- Multicenter retrospective cohort study involving 11 U.S. academic medical centers.
- Included adult patients with documented positive Severe Acute Respiratory Syndrome Coronavirus 2 tests who underwent CPR/defibrillation for IHCA between March 1, 2020, and May 31, 2020.
- Primary outcome was 30-day survival post-IHCA.
Main Results:
- 260 IHCAs occurred in COVID-19 patients; median age 69, 71.5% male.
- Common presenting rhythms were pulseless electrical activity (45.0%) and asystole (44.6%).
- Return of spontaneous circulation (ROSC) was 22.3%, 11.9% survived to discharge, and 12.3% survived to 30 days. Hospitals with higher IHCA volume showed considerably lower ROSC and 30-day survival rates.
Conclusions:
- Achieved ROSC and 30-day survival rates were 22.3% and 12.3%, respectively.
- Significant variations in center-level outcomes were observed.
- These variations may explain previously reported poor survival rates in COVID-19 patients with IHCA.
Background:
Coronavirus Disease 2019 (COVID-19) has caused over 1 200 000 deaths worldwide as of November 2020. However, little is known about the clinical outcomes among hospitalized patients with active COVID-19 after in-hospital cardiac arrest (IHCA).
Aim:
We aimed to characterize outcomes from IHCA in patients with COVID-19 and to identify patient- and hospital-level variables associated with 30-day survival.
Methods:
We conducted a multicentre retrospective cohort study across 11 academic medical centres in the U.S. Adult patients who received cardiopulmonary resuscitation and/or defibrillation for IHCA between March 1, 2020 and May 31, 2020 who had a documented positive test for Severe Acute Respiratory Syndrome Coronavirus 2 were included. The primary outcome was 30-day survival after IHCA.
Results:
There were 260 IHCAs among COVID-19 patients during the study period. The median age was 69 years (interquartile range 60-77), 71.5% were male, 49.6% were White, 16.9% were Black, and 16.2% were Hispanic. The most common presenting rhythms were pulseless electrical activity (45.0%) and asystole (44.6%). ROSC occurred in 58 patients (22.3%), 31 (11.9%) survived to hospital discharge, and 32 (12.3%) survived to 30 days. Rates of ROSC and 30-day survival in the two hospitals with the highest volume of IHCA over the study period compared to the remaining hospitals were considerably lower (10.8% vs. 64.3% and 5.9% vs. 35.7% respectively, p < 0.001 for both).
Conclusions:
We found rates of ROSC and 30-day survival of 22.3% and 12.3% respectively. There were large variations in centre-level outcomes, which may explain the poor survival in prior studies.
More Related Videos
05:36Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine
Published on: January 30, 2020
08:19Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs
Published on: July 12, 2022
Related Concept Videos
Cardiopulmonary Resuscitation III: AED Use
Cardiopulmonary Resuscitation IV: Pharmacological Management
Acute Coronary Syndrome IV: Interprofessional Care
Cardiopulmonary Resuscitation I: Adult
Introduction Cardiac Emergencies
Acute Coronary Syndrome V: Nursing Management